Table 2.
Group | remission group | non-remission group | P |
---|---|---|---|
Quantity | 67(65.69 %) | 35(34.31 %) | |
Age (mean ± standard deviation) | 62.46 ± 8.47 | 61.63 ± 8.57 | 0.2961 |
Gender | 60(89.55 %) | 0.0062 | |
Man | 7(10.45 %) | 23(65.71 %) | |
Woman | 12(34.29 %) | ||
Smoke | 48(71.64 %) | 0.0515 | |
Yes | 19(28.36 %) | 18(51.43 %) | |
No | 17(48.57 %) | ||
History of chronic lung disease | 8(11.94 %) | >0.9999 | |
Yes | 59(88.06 %) | 4(11.43 %) | |
No | 31(88.57 %) | ||
Pathological pattern | 39(58.21 %) | 0.0971 | |
squamous carcinoma | 28(41.79 %) | 14(40.00 %) | |
Adenocarcinoma and others | 21(60.00 %) | ||
Staging | 2(2.99 %) | 0.6590 | |
II | 44(65.67 %) | 2(5.71 %) | |
III | 21(31.34 %) | 20(57.14 %) | |
IV | 13(37.14 %) |